Author
Listed:
- Jeong Hyun Lee
(The Scripps Research Institute
International AIDS Vaccine Initiative Neutralizing Antibody Center and the Collaboration for AIDS Vaccine Discovery (CAVD), The Scripps Research Institute
Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, The Scripps Research Institute)
- Daniel P. Leaman
(The Scripps Research Institute)
- Arthur S. Kim
(The Scripps Research Institute)
- Alba Torrents de la Peña
(Academic Medical Center)
- Kwinten Sliepen
(Academic Medical Center)
- Anila Yasmeen
(Weill Medical College of Cornell University)
- Ronald Derking
(Academic Medical Center)
- Alejandra Ramos
(International AIDS Vaccine Initiative Neutralizing Antibody Center and the Collaboration for AIDS Vaccine Discovery (CAVD), The Scripps Research Institute
The Scripps Research Institute)
- Steven W. de Taeye
(Academic Medical Center)
- Gabriel Ozorowski
(The Scripps Research Institute
International AIDS Vaccine Initiative Neutralizing Antibody Center and the Collaboration for AIDS Vaccine Discovery (CAVD), The Scripps Research Institute
Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, The Scripps Research Institute)
- Florian Klein
(Laboratory of Molecular Immunology, The Rockefeller University)
- Dennis R. Burton
(International AIDS Vaccine Initiative Neutralizing Antibody Center and the Collaboration for AIDS Vaccine Discovery (CAVD), The Scripps Research Institute
The Scripps Research Institute
Ragon Institute of MGH, MIT and Harvard)
- Michel C. Nussenzweig
(Laboratory of Molecular Immunology, The Rockefeller University
Howard Hughes Medical Institute, The Rockefeller University)
- Pascal Poignard
(International AIDS Vaccine Initiative Neutralizing Antibody Center and the Collaboration for AIDS Vaccine Discovery (CAVD), The Scripps Research Institute
The Scripps Research Institute)
- John P. Moore
(Weill Medical College of Cornell University)
- Per Johan Klasse
(Weill Medical College of Cornell University)
- Rogier W. Sanders
(Academic Medical Center
Weill Medical College of Cornell University)
- Michael B. Zwick
(The Scripps Research Institute)
- Ian A. Wilson
(The Scripps Research Institute
International AIDS Vaccine Initiative Neutralizing Antibody Center and the Collaboration for AIDS Vaccine Discovery (CAVD), The Scripps Research Institute
Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, The Scripps Research Institute
Skaggs Institute for Chemical Biology, The Scripps Research Institute)
- Andrew B. Ward
(The Scripps Research Institute
International AIDS Vaccine Initiative Neutralizing Antibody Center and the Collaboration for AIDS Vaccine Discovery (CAVD), The Scripps Research Institute
Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, The Scripps Research Institute)
Abstract
The recent identification of three broadly neutralizing antibodies (bnAbs) against gp120–gp41 interface epitopes has expanded the targetable surface on the HIV-1 envelope glycoprotein (Env) trimer. By using biochemical, biophysical and computational methods, we map the previously unknown trimer epitopes of two related antibodies, 3BC315 and 3BC176. A cryo-EM reconstruction of a soluble Env trimer bound to 3BC315 Fab at 9.3 Å resolution reveals that the antibody binds between two gp41 protomers, and neutralizes the virus by accelerating trimer decay. In contrast, bnAb 35O22 binding to a partially overlapping quaternary epitope at the gp120–gp41 interface does not induce decay. A conserved gp41-proximal glycan at N88 was also shown to play a role in the binding kinetics of 3BC176 and 3BC315. Finally, our data suggest that the dynamic structure of the Env trimer influences exposure of bnAb epitopes.
Suggested Citation
Jeong Hyun Lee & Daniel P. Leaman & Arthur S. Kim & Alba Torrents de la Peña & Kwinten Sliepen & Anila Yasmeen & Ronald Derking & Alejandra Ramos & Steven W. de Taeye & Gabriel Ozorowski & Florian Kle, 2015.
"Antibodies to a conformational epitope on gp41 neutralize HIV-1 by destabilizing the Env spike,"
Nature Communications, Nature, vol. 6(1), pages 1-14, November.
Handle:
RePEc:nat:natcom:v:6:y:2015:i:1:d:10.1038_ncomms9167
DOI: 10.1038/ncomms9167
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:6:y:2015:i:1:d:10.1038_ncomms9167. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.